|
|
|
|
| Advertisement |
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes.  Learn more
|
|
| Regulatory |
 |
|
What's In—and Out—of the “Cures” Bill |
Congress took a major step last week towards shoring up FDA operations and biomedical research supported by the National Institutes of Health with House passage of the 21st Century Cures bill. Jill Wechsler reports
… /Read more/ |
|
|
| Advertisement |
Personalized medicine: Commercializing drugs with companion diagnostics
On Demand
 Learn more
|
|
| Advertisement |
How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors
On Demand
 Learn more
|
|
|
|
ADVERTISEMENT
|
| Industry update |
| //Codexis (Redwood City, CA) named Bernard J. Kelley as Chairman of the Board. Mr. Kelley has served as a Director of Codexis since April 2004.//Taro Pharmaceutical Industries (Hawthorne, NY) has appointed Mr. Abhay Gandhi as Interim Chief Executive Officer, effective January 1, 2017. Mr. Gandhi will serve in this role until the arrival in April 2017 of Mr. Uday Baldota, Taro's recently appointed CEO.//Innovative Medicines Canada (Ottawa) has appointed Pamela Fralick as its new President. Ms. Fralick is the former President and CEO of the Canadian Cancer Society.// |
|
|
